More precisely, the altered gut microbiota composition by prebiotics improves leptin sensitivity in diet-induced obese and type 2 diabetic mice [211], suggesting the gut microbiota modulations could be a novel therapeutic target to reset leptin sensitivity during obesity. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.